{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:02:15Z","timestamp":1789552935540,"version":"build-2803163510"},"reference-count":175,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Analytical Chemistry"],"DOI":"10.1080\/10408347.2026.2723461","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:03:46Z","timestamp":1789549426000},"page":"1-44","source":"Crossref","is-referenced-by-count":0,"title":["Trends and Advances in Analytical Methodologies for Favipiravir Determination Across Diverse Matrices"],"prefix":"10.1080","author":[{"given":"Niralee J.","family":"Malaviya","sequence":"first","affiliation":[{"name":"Department of Chemistry, School of Science, Dr. Subhash University","place":["Junagadh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik L.","family":"Varu","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Science, Dr. Subhash University","place":["Junagadh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunal A.","family":"Ambasana","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Forensic Science, Bhakta Kavi Narsinh Mehta University","place":["Junagadh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_3_5_2_1","first-page":"143","article-title":"Favipiravir in COVID-19","volume":"19","author":"Seneviratne S. L.","year":"2020","unstructured":"Seneviratne, S. L.; Abeysuriya, V.; De Mel, S.; De Zoysa, I.; Niloofa, R. Favipiravir in COVID-19. Int. J. Prog. Sci. Technol 2020, 19, 143\u2013145.","journal-title":"Int. J. Prog. Sci. Technol"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.069"},{"key":"e_1_3_5_4_1","unstructured":"PubChem. Favipiravir. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Favipiravir (accessed May 27 2026)."},{"key":"e_1_3_5_5_1","unstructured":"ChemicalBook. Favipiravir. https:\/\/www.chemicalbook.com\/ChemicalProductProperty_EN_CB71055246.htm (accessed May 27 2026)."},{"key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-323-85156-5.00013-4","volume-title":"Coronavirus Drug Discovery","author":"Nainwal L. M.","year":"2022","unstructured":"Nainwal, L. M. FDA Coronavirus Treatment Acceleration Program: Approved Drugs and Those in Clinical Trials. In Coronavirus Drug Discovery; Elsevier: Amsterdam, The Netherlands, 2022; pp 249\u2013264."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068347"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002535"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp274"},{"key":"e_1_3_5_10_1","article-title":"Ebola Drug from Japan May Emerge among Key Candidates","author":"Koons C.","year":"2014","unstructured":"Koons, C. Ebola Drug from Japan May Emerge among Key Candidates. Bloomberg, August 7, 2014,","journal-title":"Bloomberg"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-18"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107512"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30016-9"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1154814"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00324"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.supflu.2022.105539"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.338418"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-021-05107-2"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0527.3375"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-022-05213-9"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2022.109609"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/bios13020243"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-01023-z"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45353-3"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.108696"},{"key":"e_1_3_5_26_1","first-page":"e202401789","article-title":"Construction of a Voltammetric Sensor Based on Niobium Supported on Zirconium Oxide\u2013Carbon Nanotubes for the Determination of Favipiravir, an Antiviral Drug Used against COVID-19","volume":"9","author":"Kutluay Baytak A.","year":"2024","unstructured":"Kutluay Baytak, A.; Aslanoglu, M. Construction of a Voltammetric Sensor Based on Niobium Supported on Zirconium Oxide\u2013Carbon Nanotubes for the Determination of Favipiravir, an Antiviral Drug Used against COVID-19. ChemSelect 2024, 9, e202401789.","journal-title":"ChemSelect"},{"key":"e_1_3_5_27_1","article-title":"G\/In2O3 Nanocatalyst Modified Pencil Graphite Electrode for the Electrochemical Detection of Favipiravir","volume":"14","author":"Sanjeevagol S.","year":"2024","unstructured":"Sanjeevagol, S.; Manjanna, J.; Chaithra, R. G\/In2O3 Nanocatalyst Modified Pencil Graphite Electrode for the Electrochemical Detection of Favipiravir. Iran. J. Catal 2024, 14,1.","journal-title":"Iran. J. Catal"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1149\/1945-7111\/ad1b7a"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2025.105975"},{"key":"e_1_3_5_30_1","first-page":"1089","article-title":"Determination of Antiviral Drug Favipiravir from Biological Samples by Using Molecularly Imprinted Polymer-Based Electrochemical Sensor","volume":"48","author":"Dindar \u00c7. K.","year":"2024","unstructured":"Dindar, \u00c7. K.; Uslu, B. Determination of Antiviral Drug Favipiravir from Biological Samples by Using Molecularly Imprinted Polymer-Based Electrochemical Sensor. J. Fac. Pharm. Ankara Univ 2024, 48, 1089\u20131097.","journal-title":"J. Fac. Pharm. Ankara Univ"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2025.128084"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.112364"},{"key":"e_1_3_5_33_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.52711\/0974-4150.2022.00007","article-title":"A Validated Potentiometric Titration Method for Quantitative Determination of Favipiravir from Pharmaceutical Preparation","volume":"15","author":"Rele Rajan V.","year":"2022","unstructured":"Rele Rajan, V.; Tiwatane Prathamesh, P. A Validated Potentiometric Titration Method for Quantitative Determination of Favipiravir from Pharmaceutical Preparation. Asian J. Res. Chem 2022, 15, 49.","journal-title":"Asian J. Res. Chem"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.111390"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1039\/d3ra07356d"},{"key":"e_1_3_5_36_1","doi-asserted-by":"crossref","unstructured":"Nasr M. S.; Talaat W.; Kaddah M. M.; Omran G.; and Morshedy S. Eco\u2010Friendly Analytical Approaches for the Quantification of Molnupiravir and Favipiravir using Capillary Zone Electrophoresis and Derivative Ratio Spectrophotometry. ChemistrySelect 2024 9(20) e202400508.","DOI":"10.1002\/slct.202400508"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2020.114199.14725"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-023-02807-2"},{"key":"e_1_3_5_39_1","first-page":"1","article-title":"UV-Spectrophotometric Method Development and Validation of Favipiravir in Pure and Formulation","volume":"6","author":"Chiranjeevi P.","year":"2024","unstructured":"Chiranjeevi, P.; Rao, K. V.; Priya, M. B. N.; Sireesha, P.; Durga, V. L.; Mayuri, Y.; Babu, K. R. UV-Spectrophotometric Method Development and Validation of Favipiravir in Pure and Formulation. Int. J. Multidiscip. Res 2024, 6, 1\u20138.","journal-title":"Int. J. Multidiscip. Res"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072330"},{"key":"e_1_3_5_41_1","first-page":"672","article-title":"An Economical Assay Method for the Spectroscopic Quantification of an Antiviral Drug","volume":"21","author":"Gummadi S.","year":"2022","unstructured":"Gummadi, S.; Goswami, A. K.; Jana, S.; Challa, K. C. An Economical Assay Method for the Spectroscopic Quantification of an Antiviral Drug. Ymer 2022, 21, 672\u2013684.","journal-title":"Ymer"},{"key":"e_1_3_5_42_1","first-page":"299","article-title":"Simple Extractive Spectrophotometric Method for Determination of Favipiravir from Pharmaceutical Formulation","volume":"15","author":"Rajan V. R.","year":"2022","unstructured":"Rajan, V. R.; Prathamesh, P. T. Simple Extractive Spectrophotometric Method for Determination of Favipiravir from Pharmaceutical Formulation. Asian J. Res. Chem 2022, 15, 299\u2013302.","journal-title":"Asian J. Res. Chem"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.122070"},{"key":"e_1_3_5_44_1","first-page":"5767","article-title":"Quantitative Analysis of Favipiravir in Bulk and Pharmaceutical Dosage Forms Using UV\u2013Visible Spectrophotometer","volume":"12","author":"Ramadoss K.","year":"2023","unstructured":"Ramadoss, K.; Subramaniam, R.; Selvakumar, A.; Subramani, S.; Solomon, A. Quantitative Analysis of Favipiravir in Bulk and Pharmaceutical Dosage Forms Using UV\u2013Visible Spectrophotometer. J. Med. Pharm. Allied Sci 2023, 12, 5767\u20135772.","journal-title":"J. Med. Pharm. Allied Sci"},{"key":"e_1_3_5_45_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5530\/ijpi.13.2.039","article-title":"A Green Eco-Friendly Analytical Method Development, Validation, and Stress Degradation Studies of Favipiravir in Bulk and Different Tablet Dosage Forms by UV-Spectrophotometric and RP-HPLC Methods with Their Comparison by Using ANOVA and In Vitro Dissolution Studies","volume":"13","author":"Chakraborty S.","year":"2023","unstructured":"Chakraborty, S.; Mondal, S. A Green Eco-Friendly Analytical Method Development, Validation, and Stress Degradation Studies of Favipiravir in Bulk and Different Tablet Dosage Forms by UV-Spectrophotometric and RP-HPLC Methods with Their Comparison by Using ANOVA and In Vitro Dissolution Studies. Int. J. Pharm. Investig 2023, 13, 1\u201310.","journal-title":"Int. J. Pharm. Investig"},{"key":"e_1_3_5_46_1","article-title":"Determination of Favipiravir in Bulk and Pharmaceutical Formula by Spectroscopic Method Using Phenol Red Reagent","author":"More J. D.","year":"2023","unstructured":"More, J. D.; Suryawanshi, C. P.; Sinhal, A. P.; Jadhav, N. Determination of Favipiravir in Bulk and Pharmaceutical Formula by Spectroscopic Method Using Phenol Red Reagent. Int. J. Pharm. Sci 2023, 07, 255.","journal-title":"Int. J. Pharm. Sci"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00971-5"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00998-8"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-01034-5"},{"key":"e_1_3_5_50_1","first-page":"27","article-title":"Application of Reactive Dyes in Validation of Favipiravir from Pharmaceutical Dosages","volume":"16","author":"Rajan V. R.","year":"2023","unstructured":"Rajan, V. R.; Prathamesh, P. T. Application of Reactive Dyes in Validation of Favipiravir from Pharmaceutical Dosages. Asian J. Res. Chem 2023, 16, 27\u201330.","journal-title":"Asian J. Res. Chem"},{"key":"e_1_3_5_51_1","first-page":"259","article-title":"Development and Validation of UV Spectrophotometric Method for Estimation of Favipiravir","volume":"12","author":"Bhavar G.","year":"2023","unstructured":"Bhavar, G.; Aher, K.; Khairnar, H.; Chaudhari, H.; Shevatkar, J.; Sisodiya, K.; Gadara, J. Development and Validation of UV Spectrophotometric Method for Estimation of Favipiravir. Eur. Chem. Bull 2023, 12, 259\u2013269.","journal-title":"Eur. Chem. Bull"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-023-02984-4"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-024-01142-4"},{"key":"e_1_3_5_54_1","first-page":"1","article-title":"Spectrophotometric Determination of Favipiravir in Bulk and Pharmaceutical Formulation Using Bromothymol Blue Reagent","volume":"14","author":"Rebbbaniboni N.","year":"2024","unstructured":"Rebbbaniboni, N.; Mahithavani, S.; Somayala, G.; Lakshman, M. V. S.; Bandla, J. Spectrophotometric Determination of Favipiravir in Bulk and Pharmaceutical Formulation Using Bromothymol Blue Reagent. Int. J. Pharm. Investig 2024, 14, 1\u20137.","journal-title":"Int. J. Pharm. Investig"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.52711\/2231-5675.2024.00012"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i48B33283"},{"key":"e_1_3_5_57_1","first-page":"4354173","article-title":"Simultaneous Sensitive Spectroscopic Determination of Anti-COVID-19 Agents in Raw Materials and Pharmaceuticals: In-Depth Green Assessment","author":"Noureldeen D. A.","year":"2023","unstructured":"Noureldeen, D. A.; Boushra, J. M.; Lashien, A. S.; Abdel Hakiem, A. F.; Attia, T. Z. Simultaneous Sensitive Spectroscopic Determination of Anti-COVID-19 Agents in Raw Materials and Pharmaceuticals: In-Depth Green Assessment. SSRN Electron. J 2023, 4354173.","journal-title":"SSRN Electron. J"},{"key":"e_1_3_5_58_1","first-page":"155","article-title":"A Novel Ratio Difference Spectrophotometric Method for the Simultaneous Determination of Molnupiravir and Favipiravir in Binary Mixture","volume":"50","author":"Ate\u015f A. K.","year":"2026","unstructured":"Ate\u015f, A. K. A Novel Ratio Difference Spectrophotometric Method for the Simultaneous Determination of Molnupiravir and Favipiravir in Binary Mixture. J. Fac. Pharm. Ankara Univ 2026, 50, 155\u2013164.","journal-title":"J. Fac. Pharm. Ankara Univ"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.119241"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106189"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10895-022-02997-0"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25820-z"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.121625"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.122880"},{"key":"e_1_3_5_65_1","first-page":"1","article-title":"Fluorimetric Determination of Antiviral (COVID-19) Drug Favipiravir in Bulk and Pharmaceutical Dosage Forms","volume":"13","author":"Sri K. B.","year":"2023","unstructured":"Sri, K. B.; Fatima, M. S.; Banu, S.; Sumakanth, M. Fluorimetric Determination of Antiviral (COVID-19) Drug Favipiravir in Bulk and Pharmaceutical Dosage Forms. J. Drug Delivery Ther 2023, 13, 1\u20136.","journal-title":"J. Drug Delivery Ther"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-024-03760-4"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.110418"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/bio.4837"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2024.123823"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2025.125983"},{"key":"e_1_3_5_71_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13065-026-01724-1","article-title":"A Sensitive, Aqueous-Based Spectrofluorimetric Approach for the Determination of Favipiravir in Presence of Its Acid-Induced Degradation Product","volume":"20","author":"El-Fattah M. H. A.","year":"2026","unstructured":"El-Fattah, M. H. A.; Sharaf, Y. A.; El-Sayed, H. M.; Hassan, S. A. A Sensitive, Aqueous-Based Spectrofluorimetric Approach for the Determination of Favipiravir in Presence of Its Acid-Induced Degradation Product. BMC Chem. 2026, 20, 56.","journal-title":"BMC Chem."},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2026.117560"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-35670-8"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-4150.2021.00054"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2022.123827"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijcpr.2022v14i5.2022"},{"key":"e_1_3_5_77_1","first-page":"449","article-title":"Green Analytical Approach: Quantitative Estimation of Favipiravir in Bulk and Pharmaceutical Dosage Form Using Fourier Transform Infrared Spectroscopy","volume":"24","author":"Mallepelli S.","year":"2023","unstructured":"Mallepelli, S.; Garlapati, A. Green Analytical Approach: Quantitative Estimation of Favipiravir in Bulk and Pharmaceutical Dosage Form Using Fourier Transform Infrared Spectroscopy. Spectroscopy 2023, 24, 449\u2013456.","journal-title":"Spectroscopy"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.107101"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202200236"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202200489"},{"key":"e_1_3_5_81_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5530\/ijpi.13.3.071","article-title":"Stability-Indicating HPTLC Method Development and Validation for Quantification of Favipiravir in Bulk and Commercial Film-Coated Tablets","volume":"13","author":"Balap A. R.","year":"2023","unstructured":"Balap, A. R.; Dudhe, A. P. Stability-Indicating HPTLC Method Development and Validation for Quantification of Favipiravir in Bulk and Commercial Film-Coated Tablets. Int. J. Pharm. Investig 2023, 13, 1\u20139.","journal-title":"Int. J. Pharm. Investig"},{"key":"e_1_3_5_82_1","first-page":"817","article-title":"Development and Validation of Stability-Indicating High-Performance Thin-Layer Chromatography Method for Estimation of Favipiravir by Quality by Design Approach","volume":"3","author":"Bhosale A. A.","year":"2024","unstructured":"Bhosale, A. A.; Mali, N. S.; Rukhe, N. B.; Pawar, A. A.; More, P. M.; Jain, H. K.; Vitukade, G. A. Development and Validation of Stability-Indicating High-Performance Thin-Layer Chromatography Method for Estimation of Favipiravir by Quality by Design Approach. Int. J. Pharm. Res. Technol 2024, 3, 817\u2013833.","journal-title":"Int. J. Pharm. Res. Technol"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2025.115779"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-024-01195-5"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-025-01439-9"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-6252"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.114225"},{"key":"e_1_3_5_88_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.33808\/clinexphealthsci.992869","article-title":"Development and Validation of a Rapid HPLC-DAD Method for Determination of Favipiravir in Pharmaceutical Formulation","volume":"12","author":"Ta\u015fk\u0131n D.","year":"2021","unstructured":"Ta\u015fk\u0131n, D. Development and Validation of a Rapid HPLC-DAD Method for Determination of Favipiravir in Pharmaceutical Formulation. Clin. Exp. Health Sci 2021, 12, 648\u2013652.","journal-title":"Clin. Exp. Health Sci"},{"key":"e_1_3_5_89_1","first-page":"181","article-title":"A Validated High-Performance Liquid Chromatographic Method for the Quantification of Favipiravir by PDA Detector","volume":"11","author":"Nadendla R.","year":"2021","unstructured":"Nadendla, R.; Abhinandana, P. A Validated High-Performance Liquid Chromatographic Method for the Quantification of Favipiravir by PDA Detector. Int. J. Life Sci. Pharma Res 2021, 11, 181\u2013188.","journal-title":"Int. J. Life Sci. Pharma Res"},{"key":"e_1_3_5_90_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.9734\/jpri\/2021\/v33i47A33014","article-title":"Bioanalytical Method Development and Validation for the Determination of Favipiravir in Spiked Human Plasma by Using RP-HPLC","volume":"33","author":"Duse P. V.","year":"2021","unstructured":"Duse, P. V.; Baheti, K. G. Bioanalytical Method Development and Validation for the Determination of Favipiravir in Spiked Human Plasma by Using RP-HPLC. J. Pharm. Res. Int 2021, 33, 275\u2013281.","journal-title":"J. Pharm. Res. Int"},{"key":"e_1_3_5_91_1","article-title":"Development and Validation of UPLC-MS\/MS Method for Determination of Favipiravir Tablet Dosage Form and Evaluation of Its Behavior under Forced Conditions","author":"G\u00f6kce S.","year":"2021","unstructured":"G\u00f6kce, S.; H\u00f6l, A.; Bulduk, I. Development and Validation of UPLC-MS\/MS Method for Determination of Favipiravir Tablet Dosage Form and Evaluation of Its Behavior under Forced Conditions. J. Pharm. Biomed. Anal 2021,33, 56A, 130.","journal-title":"J. Pharm. Biomed. Anal"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.122768"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114057"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5098"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2021v13i4.40530"},{"key":"e_1_3_5_96_1","first-page":"60","article-title":"RP-HPLC Method for Determination of Favipiravir (RdRp of RNA Viruses) in Pharmaceutical Dosage Form","volume":"16","author":"Ravisankar P.","year":"2022","unstructured":"Ravisankar, P.; Divya, B.; Sailu, A. B.; Neelima, K.; Viswanath, A.; Babu, P. S. RP-HPLC Method for Determination of Favipiravir (RdRp of RNA Viruses) in Pharmaceutical Dosage Form. Curr. Trends Biotechnol. Pharm 2022, 16, 60\u201369.","journal-title":"Curr. Trends Biotechnol. Pharm"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.33380\/2305-2066-2022-11-3-220-229"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5365"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107321"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmad020"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2021-0260"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5363"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5381"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175606"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107580"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2022.00961"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-022-02370-2"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/separations9100303"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106917"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2022.00220"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2023.123547"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.33380\/2305-2066-2023-12-3-229-239"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092356"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115436"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115131"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1022605"},{"key":"e_1_3_5_117_1","first-page":"1183","article-title":"Favipiravir Determination in Pharmaceutical Formulation via HPLC Chromatographic Approach","volume":"47","author":"Aydinoglu M. S.","year":"2023","unstructured":"Aydinoglu, M. S.; Bozyel, M. Favipiravir Determination in Pharmaceutical Formulation via HPLC Chromatographic Approach. J. Fac. Pharm. Ankara Univ 2023, 47, 1183\u20131191.","journal-title":"J. Fac. Pharm. Ankara Univ"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109334"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8847958"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-023-04777-6"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45685-0"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5689"},{"key":"e_1_3_5_123_1","first-page":"2455","article-title":"RP-HPLC Method Development and Validation for Determination of Favipiravir in Pure Substances and Marketed Tablet Dosage Form","volume":"8","author":"Bathula S.","year":"2023","unstructured":"Bathula, S.; Sammaiah, G.; Warangal, T. RP-HPLC Method Development and Validation for Determination of Favipiravir in Pure Substances and Marketed Tablet Dosage Form. Int. J. Adv. Res. Med. Pharm. Sci 2023, 8, 2455\u20136998.","journal-title":"Int. J. Adv. Res. Med. Pharm. Sci"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5816"},{"key":"e_1_3_5_125_1","first-page":"1183","article-title":"Favipiravir Determination in Pharmaceutical Formulation via HPLC Chromatographic Approach. Turk","volume":"20","author":"Aydinoglu M. S.","year":"2023","unstructured":"Aydinoglu, M. S.; Bozyel, M. Favipiravir Determination in Pharmaceutical Formulation via HPLC Chromatographic Approach. Turk. J. Pharm. Sci 2023, 20, 1183\u20131191.","journal-title":"J. Pharm. Sci"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.26650\/IstanbulJPharm.2024.1409440"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.111634"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmad070"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115874"},{"key":"e_1_3_5_130_1","first-page":"1040","article-title":"Development and Validation of a Sensitive, Fast and Simple LC-MS\/MS Method for the Quantitation of Favipiravir Pure and Tablet Dosage Forms","volume":"58","author":"Rao N. S.","year":"2024","unstructured":"Rao, N. S.; Adimulapu, A. K.; Kumari, M. R.; Rao, P. V.; Anusha, A.; Thathapudi, D. Development and Validation of a Sensitive, Fast and Simple LC-MS\/MS Method for the Quantitation of Favipiravir Pure and Tablet Dosage Forms. Indian J. Pharm. Educ. Res 2024, 58, 1040\u20131048.","journal-title":"Indian J. Pharm. Educ. Res"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsad147"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202402900"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109815"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.2174\/0115734129249314231122071145"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.111197"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1002\/cem.3548"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.52756\/ijerr.2024.v42.021"},{"key":"e_1_3_5_138_1","unstructured":"Patra S. K.; Shilpavathi L.; Pani M. K.; Mishra P.; Parida L. Analytical Method Development and Validation for the Quantitative Estimation of Favipiravir in API Form and Marketed Pharmaceutical Dosage Form by Using RP-HPLC 2025."},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337-024-04477-1"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.63682\/jns.v14i32S.8145"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321474"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-024-01169-9"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2025.124615"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmaf015"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2025.466229"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.37285\/ijpsn.2025.18.3.5"},{"key":"e_1_3_5_147_1","first-page":"59","article-title":"A Comprehensive LC-MS\/MS Method for Detecting Genotoxic Nitrosamine Impurities in Favipiravir API","author":"Remidicherla S. S.","year":"2025","unstructured":"Remidicherla, S. S.; Chakravarthi, G.; Malothu, N.; Reddy, A. R. A Comprehensive LC-MS\/MS Method for Detecting Genotoxic Nitrosamine Impurities in Favipiravir API. Indian J. Pharm. Educ. Res 2025, 59.","journal-title":"Indian J. Pharm. Educ. Res"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-25470-x"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-025-01244-4"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-41131-z"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sampre.2023.100058"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020529"},{"key":"e_1_3_5_153_1","volume-title":"Validation of Analytical Procedures: Text and Methodology Q2(R1)","author":"International Council for Harmonisation (ICH)","year":"2005","unstructured":"International Council for Harmonisation (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R1); ICH: Geneva, Switzerland, 2005."},{"key":"e_1_3_5_154_1","volume-title":"Validation of Analytical Procedures: Text and Methodology Q2(R2)","author":"International Council for Harmonisation (ICH)","year":"2022","unstructured":"International Council for Harmonisation (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R2); ICH: Geneva, Switzerland, 2022."},{"key":"e_1_3_5_155_1","volume-title":"21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals","author":"U.S. Food and Drug Administration","year":"2023","unstructured":"U.S. Food and Drug Administration. 21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals; FDA: Silver Spring, MD, 2023."},{"key":"e_1_3_5_156_1","volume-title":"Analytical Procedures and Methods Validation: Chemistry, Manufacturing, and Controls Documentation; Guidance for Industry","author":"U.S. Food and Drug Administration","year":"2000","unstructured":"U.S. Food and Drug Administration. Analytical Procedures and Methods Validation: Chemistry, Manufacturing, and Controls Documentation; Guidance for Industry (Draft); FDA: Rockville, MD, 2000."},{"key":"e_1_3_5_157_1","volume-title":"ISO\/IEC 17025: General Requirements for the Competence of Testing and Calibration Laboratories","author":"International Organization for Standardization","year":"2005","unstructured":"International Organization for Standardization. ISO\/IEC 17025: General Requirements for the Competence of Testing and Calibration Laboratories; ISO: Geneva, Switzerland, 2005."},{"key":"e_1_3_5_158_1","volume-title":"United States Pharmacopeia 30\u2013National Formulary 25, General Chapter <1225> Validation of Compendial Methods","author":"United States Pharmacopeial Convention","year":"2007","unstructured":"United States Pharmacopeial Convention. United States Pharmacopeia 30\u2013National Formulary 25, General Chapter <1225> Validation of Compendial Methods; USP: Rockville, MD, 2007."},{"key":"e_1_3_5_159_1","volume-title":"WHO Technical Report Series No. 1019: Guidelines for Method Validation","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. WHO Technical Report Series No. 1019: Guidelines for Method Validation; WHO: Geneva, Switzerland, 2019."},{"key":"e_1_3_5_160_1","volume-title":"AOAC Peer-Verified Methods Program: Manual on Policies and Procedures; AOAC","author":"AOAC International","year":"1998","unstructured":"AOAC International. AOAC Peer-Verified Methods Program: Manual on Policies and Procedures; AOAC International: Arlington, VA, 1998."},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1039\/D5GC01865A"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.51435\/turkjac.935765"},{"key":"e_1_3_5_163_1","first-page":"64","article-title":"A Review on Various Novel Analytical Methods Reported on Favipiravir Estimation","volume":"2","author":"Harshitha M.","year":"2024","unstructured":"Harshitha, M.; Sowmya, H. G.; Naveen Kumar, G. S. A Review on Various Novel Analytical Methods Reported on Favipiravir Estimation. J. Pharma Insights Res 2024, 2, 64\u201371.","journal-title":"J. Pharma Insights Res"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3RA01217G"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.21608\/odr.2023.182980.1021"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4RA03068A"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.113246"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.144034"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2025.2546538"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.115659"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934825601495"},{"key":"e_1_3_5_172_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1134\/S1061934825600489","article-title":"A Comprehensive Review of Analytical Methodologies for Memantine Hydrochloride","volume":"80","author":"Varu H. L.","year":"2025","unstructured":"Varu, H. L.; Parmar, H. N.; Vadhel, H. D.; Ambasana, M. A. A Comprehensive Review of Analytical Methodologies for Memantine Hydrochloride. J. Anal. Chem. 2025, 80, 1125\u20131139. 7","journal-title":"J. Anal. Chem."},{"key":"e_1_3_5_173_1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1134\/S1061934822110144","article-title":"An Expeditious Spectrophotometric Estimation of Memantine Hydrochloride by Facile Derivatization Using N, N-Dimethyl Aniline","volume":"77","author":"Varu H. L.","year":"2022","unstructured":"Varu, H. L.; Kapuriya, N. P.; Bhalodia, J. J.; Patel, R. B.; Bapodra, A. H.; Ambasana, M. A. An Expeditious Spectrophotometric Estimation of Memantine Hydrochloride by Facile Derivatization Using N, N-Dimethyl Aniline. J. Anal. Chem. 2022, 77, 1433\u20131439. 11","journal-title":"J. Anal. Chem."},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934824700813"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934823060114"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934825701746"}],"container-title":["Critical Reviews in Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2026.2723461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10408347.2026.2723461","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2026.2723461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:03:56Z","timestamp":1789549436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408347.2026.2723461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":175,"alternative-id":["10.1080\/10408347.2026.2723461"],"URL":"https:\/\/doi.org\/10.1080\/10408347.2026.2723461","relation":{},"ISSN":["1040-8347","1547-6510"],"issn-type":[{"value":"1040-8347","type":"print"},{"value":"1547-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}